Have a personal or library account? Click to login
Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress Cover

Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress

Open Access
|Apr 2011

References

  1. Alarcón GS, Tracy IC, Blackburn WD Jr. (1989). Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum. 32(6): 671-6.
  2. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D, Muhtaroglu S. (2005). Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 38: 951-965.
  3. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, Ustdal M. (2006). Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct 24: 307-311.
  4. Bauerova K, Nosalova V, Mihalova D, Navarova J. (2004). Contribution to safe anti-inflammatory therapy with indomethacin. Cent Eur J Public Health 12: S8-S10.
  5. Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. (2005a). Effect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis. Biomed Pap 149(2): 501-503.10.5507/bp.2005.09016601820
  6. Bauerova K, Valentova J, Poništ S, Navarova J, Komendova D, Mihalova D. (2005b). Effect of copper complexes on the development of adjuvant arthritis: Therapeutic and toxicological aspects. Biologia 60(17): 65-68.
  7. Bauerova K, Poništ S, Ondrejíčkova O, Komendova D, Mihalova D. (2006). Association between tissue gamma glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuroendocrinol Lett 27: 172-175.
  8. Bauerova K, Poništ S, Navarova J, Dubničkova M, Paulovičova E, Pajtinka M, Kogan G, Mihalova D. (2008a). Glucomannan in prevention of oxidative stress and inflammation occurring in adjuvant arthritis. Neuroendocrinology Lett 29(5): 691-696.
  9. Bauerova K, Kucharska J, Poništ S, Gvozdjakova A. (2008b). In Mitochondrial medicine: mitochodrial metabolism, diseases, diagnosis and therapy. Gvozdjakova, eds, pp 340-342. Springer, Netherlands
  10. Bauerova K, Paulovičova E, Mihalova D, Švík K, Poništ S. (2009). Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukán® in adjuvant arthritis. Toxicology and Industrial Health 25(4-5): 329-335.
  11. Bauerova K, Paulovičova E, Mihalova D, Dráfi F, Štrosova M, Mascia C, Biasi F, Rovensky J, Kucharska J, Gvozdjakova A, Poništ S. (2010). Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress. Acta Biochimica Polonica 57(3): 347-354.
  12. Boldyrev A. (2005). Protection of proteins from oxidative stress A new illusion or a novel strategy? Ann N Y Acad Sci 1057: 193-205.10.1196/annals.1356.01316399895
  13. Brown RK, Kelly FJ. (1996). Peroxides and other products. In: Free Radicals, a practical approach. Punchard NA, Kelly FJ, eds, pp 119-131. Oxford University Press, Oxford.
  14. Cuzzocrea S, Mazzon E, di Paola R, Genovese T, Muià C, Caputi AP, Salvemini D. (2005). Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum 52(12): 3755-60.
  15. Dinarello CA, Moldawer LL. (2002). In Pro-inflammatory and anti-inflammatory cytokines in rheumatoid arthritis: a primer for clinicians. 3rd ed., pp 351, Thousand Oaks, CA: Amgen.
  16. Drábikova K, Perečko T, Nosáľ R, Bauerova K, Poništ S, Mihalova D, Kogan G, Jančinova V. (2009). Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacological Research 59(6): 399-403.
  17. Dráfi F, Bauerova K, Valachova K, Poništ S, Mihalova D, Juránek I, Boldyrev A, Hrabárova E, Šoltés L. (2010). Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo. Neuroendocrinol Lett 31(2): 96-100.
  18. Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. (2000). Mechanisms of action of methotrexate. Immunopharmacology 47: 247-257.
  19. Gvozdjakova A, Kucharska J, Tanaka S, Neradova B, Bauerova K. (2004). Coenzyme Q10 supplementation differently modulated heart and skeletal muscle mitochondrial function induced by adjuvant arthritis. Mitochondrion 4: 20-21.
  20. He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, Chan AS, Lu AP. (2006). Anti-inflammatory and anti-oxidative effects of cherries on Freund's adjuvantinduced arthritis in rats. Scand J Rheumatol 35: 356-358.
  21. Jančinova V, Perečko T, Nosáľ R, Košťálova D, Bauerova K, Drábikova K. (2009). Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol 612(1-3): 161-6.
  22. Jančinova V, Nosáľ R, Lojek A, Číz M, Ambrozova G, Mihalova D, Bauerova K, Harmatha J, Perečko T. (2010). Formation of reactive oxygen and nitrogen species in the presence of pinosylvin - an analogue of resveratrol. Neuroendocrinol Lett. 31(2): 79-83.
  23. Kogan G, Staško A, Bauerova K, Polovka M, Šoltés L, Brezova V, Navarova J, Mihalova D. (2005). Antioxidant properties of yeast (1→3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in adjuvant arthritis. Carbohydr Polym 61: 18-28.
  24. Kogure T, Tatsumi T, Sato H, Oku Y, Kishi D, Ito T. (2010). Traditional herbal medicines (Kampo) for patients with rheumatoid arthritis receiving concomitant methotrexate: a preliminary study. Altern Ther Health Med 16: 46-51.
  25. Mačičkova T, Drábikova K, Nosáľ R, Bauerova K, Mihalova D, Harmatha J, Pečivova J. (2010). In vivo effect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis. Neuroendocrinol Lett 31(2): 91-95.
  26. Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JM, Schaible TF, Feldmann M. (1998). Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41: 1552-1563.
  27. McKendry RJ, Dale P. (1993). Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 20(11): 1850-1856.
  28. Moreland LW, Heck LW Jr, Koopman WJ. (1997). Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum 40: 397-409.
  29. Ondrejičkova O, Ziegelhoeffer A, Gabauer I, Sotnikova R, Styk J, Gibala P, Sedlak J, Horákova L. (1993). Evaluation of ischemia-reperfusion injury by malondialdehyde, glutathione and gamma-glutamyl transpeptidase: lack of specific local effects in diverse parts of the dog heart following acute coronary occlusion. Cardioscience 4: 225-230.
  30. Orlowski M, Meister A. (1970). The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci 67: 1248-1255.
  31. Perečko T, Jančinova V, Drábikova K, Nosáľ R, Harmatha J. (2008). Structureefficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosilvin and pterostilbene. Neuroendocrinol Lett 29: 802-805.
  32. Poništ S, Mihalova D, Jančinova V, Šnirc V, Ondrejičkova O, Mascia C, Poli G, Stančikova M, Nosáľ R, Bauerova K. (2010). Reduction of oxidative stress in adjuvant arthritis. Comparison of efficacy of two pyridoindoles: stobadine dipalmitate and SMe1.2HCl. Acta Biochim Pol 57(2): 223-8.
  33. Poništ S, Kucharska J, Gvozdjakova A, Komendova D, Mihalova D, Bauerova K. (2007). Mitochondrial bioenergetics of skeletal muscle studied in adjuvant arthritis. Chem Listy 101: 256-257.
  34. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D. (2010). Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4): 631-7.
  35. Sotnikova R, Poništ S, Navarova J, Mihalova D, Tomekova V, Štrosova M, Bauerova K. (2009). Effects of sesame oil in the model of adjuvant arthritis. Neuroendocrinol Lett 30: 22-24.
  36. Rovensky J, Švík K, Stančikova M, Istok R, Ebringer L, Ferenčik M. (2002). Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium. Folia Microbiol 47: 573-578.
  37. Rovensky J, Švík K, Rovenska E, Štvrtinova V, Stančikova M. (2008). Effects of purified micronized flavonoid fraction (Detralex) on prophylactic treatment of adjuvant arthritis with methotrexate in rats. Isr Med Assoc J 10: 377-380.
  38. Rovensky J, Stančikova M, Švík K, Bauerova K, Jurčovičova J. (2009a). The effects of beta-glucan isolated from Pleurotus ostreatus on methotrexate treatment in rats with adjuvant arthritis. Rheumatol Int doi: 10.1007/s00296-009-1258-z10.1007/s00296-009-1258-z20033413
  39. Rovensky J, Stančikova M, Rovenska E, Štvrtina S, Štvrtinova V, Švík K. (2009b). Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination. Ann N Y Acad Sci 1173: 798-804.10.1111/j.1749-6632.2009.04618.x19758231
  40. Sarban A, Kocyigit A, Yazar M, Isikan UE. (2005). Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38: 981-986.
  41. Štolc S, Bauer V, Benes L, Tichy M. (1983). Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: CS 229 067, SWED. 8204693-9, BELG. 894148, SWISS 651 754, BRD P-3231088, SPAIN 553 017, JAP. 151 4040.
  42. Štrosova M, Tomaškova I, Poništ S, Bauerova K, Karlovska J, Spickett CM, Horákova L. (2008). Oxidative impairment of plasma and skeletal muscle sarcoplasmic reticulum in rats with adjuvant arthritis - effects of pyridoindole antioxidants. Neuroendocrinol Lett 29: 706-711.
  43. Štrosova M, Karlovska J, Spickett CM, Országhova Z, Poništ S, Bauerova K, Mihalova D, Horákova L. (2009). Modulation of SERCA in the chronic phase of adjuvant arthritis as a possible adaptation mechanism of redox imbalance. Free Radic Res 43: 852-864.
  44. Tastekin N, Aydogdu N, Dokmeci D, Usta U, Birtane M, Erbas H, Ture M. (2007). Protective effects of L-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res 56: 303-310.
  45. Weinblatt ME. (2003). Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 62(2): 94-6.10.1136/ard.62.suppl_2.ii94176674614532160
  46. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ. (1999). A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340: 253-259.
  47. Williams HJ, Willkens RF, Samuelson CO Jr, Alarcon GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR. (1985). Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721-730.
DOI: https://doi.org/10.2478/v10102-011-0007-9 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 33 - 39
Published on: Apr 18, 2011
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2011 Katarína Bauerová, Silvester Poništ, Danica Mihalová, František Dráfi, Viera Kuncírová, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.

Volume 4 (2011): Issue 1 (March 2011)